In Vivo Effect of α(1)-Acid Glycoprotein on Pharmacokinetics of Amprenavir, a Human Immunodeficiency Virus Protease Inhibitor

Observations from early clinical pharmacology studies of amprenavir, an inhibitor of human immunodeficiency virus type 1 (HIV-1) protease that is highly bound to human plasma proteins (∼90%), showed the single-dose pharmacokinetics of amprenavir to be variable between and within individuals. A cross...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Sadler, Brian M., Gillotin, Catherine, Lou, Yu, Stein, Daniel S.
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 2001
Soggetti:	Pharmacology
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90384/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11181371/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.3.852-856.2001
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!